Clinical trial
A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder…
NCT00455130 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00455130 |
|---|---|
| Title | A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Inhaled mannitol |
| Start date | Mar 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Apr 3, 2007 |
| Last update posted | Feb 2, 2010 |
| Countries | Australia, New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: